|Articles|October 22, 2015

CRO Accelovance Selects ERT Insights Cloud

ERT announced that Accelovance, a CRO focusing on oncology, vaccines, and general medicine, has selected ERT’s Insights Cloud to replace its CTMS system.

ERT’s Insights Cloud includes a technology-agnostic data hub with proprietary integration framework that enables data integration from leading data capture systems including IVR / IRT, EDC, and ePRO.

Read the full release.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

CRO Accelovance Selects ERT Insights Cloud

Newsletter

Related Content

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age

Trending on Applied Clinical Trials Online

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

Accelerating Site Payments with Agentic AI: See it in Action